Literature DB >> 18728201

Proportional classifications of COPD phenotypes.

S E Marsh1, J Travers, M Weatherall, M V Williams, S Aldington, P M Shirtcliffe, A L Hansell, M R Nowitz, A A McNaughton, J B Soriano, R W Beasley.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) encompasses a group of disorders characterised by the presence of incompletely reversible airflow obstruction with overlapping subsets of different phenotypes including chronic bronchitis, emphysema or asthma. The aim of this study was to determine the proportion of adult subjects aged >50 years within each phenotypic subgroup of COPD, defined as a post-bronchodilator ratio of forced expiratory volume in 1 s/forced vital capacity (FEV(1)/FVC) <0.7, in accordance with current international guidelines.
METHODS: Adults aged >50 years derived from a random population-based survey undertook detailed questionnaires, pulmonary function tests and chest CT scans. The proportion of subjects in each of 16 distinct phenotypes was determined based on combinations of chronic bronchitis, emphysema and asthma, with and without incompletely reversible airflow obstruction defined by a post-bronchodilator FEV(1)/FVC ratio of 0.7.
RESULTS: A total of 469 subjects completed the investigative modules, 96 of whom (20.5%) had COPD. Diagrams were constructed to demonstrate the relative proportions of the phenotypic subgroups in subjects with and without COPD. 18/96 subjects with COPD (19%) had the classical phenotypes of chronic bronchitis and/or emphysema but no asthma; asthma was the predominant COPD phenotype, being present in 53/96 (55%). When COPD was defined as a post-bronchodilator FEV(1)/FVC less than the lower limit of normal, there were one-third fewer subjects with COPD and a smaller proportion without a defined emphysema, chronic bronchitis or asthma phenotype.
CONCLUSION: This study provides proportional classifications of the phenotypic subgroups of COPD which can be used as the basis for further research into the pathogenesis and treatment of this heterogeneous disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18728201      PMCID: PMC2862964          DOI: 10.1136/thx.2007.089193

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  39 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  Asthma as a risk factor for COPD in a longitudinal study.

Authors:  Graciela E Silva; Duane L Sherrill; Stefano Guerra; Robert A Barbee
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

3.  Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1.

Authors:  P J Sterk
Journal:  Eur Respir J       Date:  2004-04       Impact factor: 16.671

4.  Rate of decline of lung function in subjects with asthma.

Authors:  J K Peat; A J Woolcock; K Cullen
Journal:  Eur J Respir Dis       Date:  1987-03

5.  The European Community Respiratory Health Survey.

Authors:  P G Burney; C Luczynska; S Chinn; D Jarvis
Journal:  Eur Respir J       Date:  1994-05       Impact factor: 16.671

Review 6.  Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology.

Authors:  G L Snider
Journal:  Am Rev Respir Dis       Date:  1989-09

7.  The proportional Venn diagram of obstructive lung disease in the Italian general population.

Authors:  Giovanni Viegi; Gabriella Matteelli; Anna Angino; Antonio Scognamiglio; Sandra Baldacci; Joan B Soriano; Laura Carrozzi
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

8.  Decline of lung function in adults with bronchial asthma.

Authors:  C S Ulrik; P Lange
Journal:  Am J Respir Crit Care Med       Date:  1994-09       Impact factor: 21.405

9.  Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study.

Authors:  P L Enright; R A Kronmal; M Higgins; M Schenker; E F Haponik
Journal:  Am Rev Respir Dis       Date:  1993-01

10.  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care.

Authors: 
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more
  64 in total

1.  Genetic ancestry in lung-function predictions.

Authors:  Rajesh Kumar; Max A Seibold; Melinda C Aldrich; L Keoki Williams; Alex P Reiner; Laura Colangelo; Joshua Galanter; Christopher Gignoux; Donglei Hu; Saunak Sen; Shweta Choudhry; Edward L Peterson; Jose Rodriguez-Santana; William Rodriguez-Cintron; Michael A Nalls; Tennille S Leak; Ellen O'Meara; Bernd Meibohm; Stephen B Kritchevsky; Rongling Li; Tamara B Harris; Deborah A Nickerson; Myriam Fornage; Paul Enright; Elad Ziv; Lewis J Smith; Kiang Liu; Esteban González Burchard
Journal:  N Engl J Med       Date:  2010-07-07       Impact factor: 91.245

Review 2.  Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Authors:  Andrea P Rossi; Erika Zanardi; Mauro Zamboni; Andrea Rossi
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

3.  Asthma and Chronic Obstructive Pulmonary Disease Overlap: The Effect of Definitions on Measures of Burden.

Authors:  David M Mannino; Wen Oi Gan; Keele Wurst; Kourtney J Davis
Journal:  Chronic Obstr Pulm Dis       Date:  2017-02-03

4.  Long-acting β-agonists in asthma management: what is the current status?

Authors:  Satya Mysore; Richard E Ruffin
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

Review 5.  Epidemiology of the origins of airflow limitation in asthma.

Authors:  Stefano Guerra; Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2009-12

6.  Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by Using standard images--comparison with quantitative CT and pulmonary function test in the COPDGene study.

Authors:  Song Soo Kim; Joon Beom Seo; Ho Yun Lee; Dipti V Nevrekar; Anna V Forssen; James D Crapo; Joyce D Schroeder; David A Lynch
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

Review 7.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

8.  Body mass index and disease burden in elderly men and women: the Tromsø Study.

Authors:  Jan-Magnus Kvamme; Tom Wilsgaard; Jon Florholmen; Bjarne K Jacobsen
Journal:  Eur J Epidemiol       Date:  2010-01-20       Impact factor: 8.082

Review 9.  Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?

Authors:  Annelies Slats; Christian Taube
Journal:  Ther Adv Respir Dis       Date:  2015-11-22       Impact factor: 4.031

Review 10.  Asthma and chronic obstructive pulmonary disease.

Authors:  Stefano Guerra
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.